GLP1s Womens Health Women's weight loss UK

Ozempic Vulva: What's the link between Ozempic and Vaginal Health?

TribeTeam

March 25, 2026

Quick Answer: Can Ozempic Affect Vaginal Health?

Yes, indirectly. The medication known as Ozempic in the US and Wegovy (Semaglutide) in the UK is a GLP-1 receptor agonist used for weight management. While vaginal side effects are not officially listed as common adverse effects, emerging clinical observations and patient reports suggest that rapid weight loss, hormonal changes, hydration status, and microbiome shifts may influence vaginal health.

Understanding these potential links can help women manage symptoms such as vaginal dryness, pelvic floor changes, and altered microbiome balance.

What Is Ozempic and How Does It Work?

Ozempic and Wegovy contain the active ingredient Semaglutide, a GLP-1 receptor agonist. These drugs mimic the hormone Glucagon-like peptide-1, which regulates blood sugar, appetite, and digestion.

GLP-1 medications work by:

Slowing stomach emptying
Reducing appetite and calorie intake
Improving insulin secretion
Promoting significant weight loss

These metabolic effects explain why Semaglutide is widely used in obesity and diabetes management.

However, systemic metabolic changes can also influence hormones, hydration, and microbiome balance, which may indirectly affect vaginal health.

5 Ways Ozempic May Affect Vaginal Health

Vaginal Dryness

Some women report vaginal dryness while using GLP-1 medications.

Possible mechanisms include:

Reduced hydration due to decreased fluid intake
Hormonal changes during weight loss
Changes in the vaginal microbiome

Experts note that dehydration and gastrointestinal side effects associated with GLP-1 drugs can disrupt microbial ecosystems in the body.

Since the vaginal microbiome is highly sensitive to systemic changes, shifts in gut bacteria or hydration may contribute to dryness or irritation.

Changes to the Vaginal Microbiome

The vaginal microbiome, the community of bacteria that maintains vaginal health, plays a crucial role in preventing infections and maintaining normal pH.

Because GLP-1 medications alter gut motility and appetite, they may indirectly affect microbiome balance through:

dietary changes
hydration shifts
gastrointestinal side effects

These factors could influence the microbial ecosystem throughout the body, including the vaginal environment.

Pelvic Floor and Skin Changes ("Ozempic Vulva")

Some clinicians have described a phenomenon informally called "Ozempic vulva."

Symptoms reported include:

looser skin around the vulva
reduced fatty tissue
pelvic floor weakness

However, experts believe these changes are primarily related to rapid weight loss rather than the drug itself. Healthline

When body fat decreases quickly, the loss of subcutaneous fat can affect skin elasticity and pelvic tissue support.

Sexual Function Changes

Research into GLP-1 medications and female sexual health is limited.

One case report described changes in sexual function (including reduced arousal and anorgasmia) after starting GLP-1 therapy, though evidence is currently sparse.

Importantly, sexual dysfunction is not considered a recognised common side effect, and more research is needed.

Potential Changes in Infection Risk

Metabolic conditions like diabetes are known to influence vaginal infections and sexual health outcomes.

Because GLP-1 medications are frequently used in individuals with metabolic conditions, factors such as:

blood sugar changes
weight loss
microbiome shifts

may affect susceptibility to infections in some individuals.

However, direct evidence linking Semaglutide to vaginal infections is currently limited.

What Patients Are Reporting

Beyond clinical trials, patient communities have discussed vaginal health changes while using GLP-1 medications.

For example, some users report changes in vaginal odour or microbiome balance after starting Semaglutide. One user described bacterial imbalance symptoms appearing shortly after initiating treatment, despite no other lifestyle changes.

While anecdotal reports do not prove causation, they can highlight areas requiring further research.

How to Protect Vaginal Health While Using Ozempic

Stay Hydrated

GLP-1 medications reduce appetite and sometimes thirst. Maintaining adequate hydration helps:

support the vaginal microbiome
prevent dryness
reduce urinary and vaginal irritation.

Support Your Microbiome

Consider habits that promote microbial balance:

balanced nutrition
probiotic foods
limiting excessive antibiotics unless prescribed.

Strengthen the Pelvic Floor

Pelvic floor exercises or physiotherapy may help maintain vaginal and pelvic health during weight loss.

Use Vaginal Moisturisers or Lubricants

For dryness or discomfort, non-hormonal moisturisers or lubricants can help restore comfort.

Speak With a Healthcare Professional

If symptoms include:

persistent dryness
unusual discharge
pain during sex
recurrent infections

consult a clinician for assessment.

When to Seek Medical Advice

Seek professional advice if you experience:

persistent vaginal discomfort
strong or unusual odour
abnormal discharge
pain during intercourse
urinary symptoms

These could indicate conditions such as:

Bacterial Vaginosis
Vaginal Thrush
Urinary Tract Infection

Early evaluation ensures appropriate treatment.

Key Takeaways

Ozempic is a GLP-1 medication that promotes weight loss and blood sugar control.
Vaginal health changes are not common documented side effects, but some indirect effects may occur.
Potential mechanisms include rapid weight loss, dehydration, and microbiome changes.
Evidence remains limited, and more research is needed on GLP-1 medications and female sexual health.

References

Stokes V. "Ozempic vulva": GLP-1 drugs and vaginal changes. Healthline
HealthCentral. Semaglutide's impact on vaginal health and microbiome. HealthCentral
Oxford Academic. Anorgasmia following initiation of GLP-1 agonist therapy. OUP Academic
MHRA Review. The role of the vaginal microbiome in women's health. GOV.UK
Scairati et al. Diabetes, vaginal microbiome and sexual function. Maturitas (2025). PubMed

Your Tribe Is Here

This is why our platform exists. We're building a bigger, stronger tribe for women, a space where you're seen, heard, and supported.

Whether you're navigating endometriosis, fertility struggles, or simply seeking better information, our mission is to empower you with resources, education, and community.

The journey to better women's health starts here. Let's close the gap together.

Stay connected with regular updates on our social platforms and newsletters.

Because every woman deserves healthcare that sees her, hears her, and heals her.